Neuropace, Inc. Common Stock (NPCE) is a publicly traded Healthcare sector company. As of September 18, 2026, NPCE trades at $14.24 with a market cap of $483.97M and a P/E ratio of -25.01. NPCE moved +0.62% today. Year to date, NPCE is -6.72%; over the trailing twelve months it is +43.07%. Its 52-week range spans $7.56 to $19.60. Analyst consensus is strong buy with an average price target of $20.33. Rallies surfaces NPCE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NPCE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NPCE recently traded at $14.24. Market cap is $483.97M. P/E ratio is -25.01. Revenue is $98.84M.
| Metric | Value |
|---|---|
| Price | $14.24 |
| Market Cap | $483.97M |
| P/E Ratio | -25.01 |
| EPS | $-0.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.60 |
| 52-Week Low | $7.56 |
| Volume | 662 |
| Avg Volume | 0 |
| Revenue (TTM) | $98.84M |
| Net Income | $-19.11M |
| Gross Margin | 79.63% |
6 analysts cover NPCE: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.33.